QualityStocksNewsBreaks Archives - Page 335 of 1522

FridaySep 08, 2023 11:09 am

QualityStocksNewsBreaks – GolfLync Inc.’s User-Friendly and Feature-Rich Platform Driving Exceptional Growth, Engagement

GolfLync, the company behind the GolfLync app – a social network for matching golf games and players, is soaring due to its unique and feature-strong ability to bring together people who love golf, a sport that is experiencing a post-pandemic revival. “The app (available as a free download on the Apple App Store and the Google Play Store) is powered by an intelligent algorithm that brings golfers together based upon a balanced range of factors, including handicap, preferred playing style, and location, along with various related interests and specifications. The app readily supports everything from matching individual partners to building…

FridaySep 08, 2023 10:32 am

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Deploys K5 ASRs for New Client, 2nd-Year Contract Renewal

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced another new deployment and contract renewal for K5 ASRs. The announcement reads, “Knightscope’s commitment to making children safe extends beyond the classroom and into extracurricular and recreational activities. With over 3.5 billion followers worldwide, soccer is the number one sport on planet Earth, and Knightscope has begun protecting a new generation of players and fans in New York. A soccer academy and sports complex in Long Island now has a K5 ASR securing its entrance against trespassers and patrolling its parking…

ThursdaySep 07, 2023 4:55 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces 200-Patient Enrollment Milestone in Potentially Pivotal Berubicin Study

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced enrollment of 200 of the expected 243 patients in the company’s ongoing potentially pivotal study evaluating Berubicin for the treatment of recurrent Glioblastoma Multiforme (“GBM”), an aggressive and incurable form of brain cancer. “As we have noted previously, patient volunteers and their treating clinicians are the backbone of our Berubicin development program. We are deeply sensitive to the fact that these brave patients are facing the battle of their lives and we…

ThursdaySep 07, 2023 4:41 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at H.C. Wainwright 25th Annual Global Investment Conference

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing, and commercialization of rare cannabinoids and cannabinoid analogs, today announced its participation in the H.C. Wainwright Global Investment Conference, which is taking place Sept. 11-13, 2023, in New York City. The on-demand presentation by InMed’s CEO Eric A. Adams will be available beginning at 7 a.m. ET on Sept. 11 via webcast, and a recording will also be accessible on InMed’s Investor Relations website for a period of 90 days. In addition, InMed’s management team will be available for one-on-one meetings with registered investors during the conference. Interested…

ThursdaySep 07, 2023 4:25 pm

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Receives Delisting Notification from NASDAQ, Files an Appeal

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has received a letter from the Listing Qualifications Department of the NASDAQ Stock Market. The letter notes that MULN did not meet the deadline to regain compliance with NASDAQ listing requirements; the deadline was Sept. 5, 2023. According to the notice, the company failed to maintain a minimum bid price of $1. In response to the notice, Mullen Automotive has filed an appeal, requesting a hearing before the NASDAQ Listing Qualifications Panel. The company intends to request an extension of time and the opportunity to present its plan to regain…

ThursdaySep 07, 2023 4:01 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 ASRs Deployed to Oregon Hospital and Texas-Based Industrial Facility

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced a new deployment and another contract renewal, which both utilize the company’s K5 ASR. The announcement reads, “An Oregon healthcare organization with more than 70 primary care, specialty and urgent care clinics; a hospital; a children’s hospital; and a 24-hour mental and behavioral health services center, deployed its first K5 ASR at its hospital, a use case that represents one of Knightscope’s fastest growing market segments. When following Knightscope’s recommendations, ASRs can help healthcare clients meet or exceed the Joint Commission…

ThursdaySep 07, 2023 2:51 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present at Upcoming H.C. Wainwright Conference

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced that its CFO Ryan Confer will be providing an overview of the company's pioneering gene therapies for cancer and diabetes at the upcoming H.C. Wainwright 25th Annual Global Investment Conference. Confer’s presentation is scheduled to begin at 3:00 p.m. ET on Wednesday, Sep. 13, 2023. Interested parties should visit https://ibn.fm/vvilS to register and access the presentation. A recording will be available for replay on Genprex’s website for a period of time. In addition, as detailed in the announcement, Confer…

ThursdaySep 07, 2023 12:20 pm

QualityStocksNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Announces ELPIS 1 Trial Data Accepted for AHA Presentation, IBN Partnership

Longeveron (NASDAQ: LGVN; LGVNR), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, will be participating at the American Heart Association Scientific Sessions. The company announced that an abstract outlining long-term survival data from its ELPIS 1 trial of Lomecel-B(TM) for patients with HLHS has been accepted for presentation as a poster at upcoming Scientific Sessions. The sessions are slated to be held Nov. 11–13, 2023, in Philadelphia. The poster is titled “Long-Term Transplant-Free Survival Is Improved in Hypoplastic Left Heart Syndrome with Cell-Based Therapy.” The…

ThursdaySep 07, 2023 12:09 pm

QualityStocksNewsBreaks – Near Intelligence Inc. (NASDAQ: NIR) Shares New Consumer Findings for Retailers to Unlock Value, Gain Competitive Insights

Near Intelligence (NASDAQ: NIR), a global data intelligence platform that curates one of the world’s largest sources of intelligence on people and places, today announced its new study, The Great Generational Shopping Divide. The report reveals clear divisions between consumer groups, with the largest divide being generational, and finds Gen Z, Millennials, Gen X, and Boomers all have distinctly different expectations from brands, shopping preferences and outlooks for the future. High-quality consumer behavior data, which unites multiple sources to deliver insights into how consumers dine, shop, travel, work, etc., can be utilized by businesses to inform their marketing and operational…

ThursdaySep 07, 2023 11:50 am

QualityStocksNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Acquires High Times Intellectual Property, Featured in Financial News Media Article

Lucy Scientific Discovery (NASDAQ: LSDI) today announced the acquisition of the intellectual property (“IP”) of High Times, an iconic brand in the cannabis industry. In addition to the Hightimes.com domain, the transaction also includes the trademarks for the Cannabis Cup and 420.com brands and their respective domain names. In exchange, High Times will receive a 19.9% stake in Lucy's outstanding stock as well as performance-based payments. “Lucy expects this acquisition to drive high margin revenue quickly and sustainably across the cannabis sector around the world. This is a great opportunity to grow the market presence of the nearly 50-year-old High…

Site Search

Company Search

Category: QualityStocksNewsBreaks